Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ. 2004;82(6):447–53.
PubMed
PubMed Central
Google Scholar
Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86(10):805–12 (A).
Article
PubMed
PubMed Central
Google Scholar
Suazo PA, Tognarelli EI, Kalergis AM, González PA. Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease. Med Microbiol Immunol. 2015;204(2):161–76.
Article
CAS
PubMed
Google Scholar
Paz-Bailey G, Ramaswamy M, Hawkes SJ, Geretti AM. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Transm Infect. 2007;83(1):16–22.
Article
CAS
PubMed
Google Scholar
Bastien S, Mason-Jones A, De Koker P, Mmbaga E, Ross D, Mathews C. Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review. Int J STD AIDS. 2012;23(11):761–6.
Article
CAS
PubMed
Google Scholar
Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, Puren A, Duvvury N. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506.
Article
PubMed
PubMed Central
Google Scholar
Ramjee G, Williams B, Gouws E, Van Dyck E, De Deken B, Karim SA. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr. 2005;39(3):333–9.
Article
PubMed
Google Scholar
Abbai NS, Wand H, Ramjee G. Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal. BMC Res Notes. 2015;8(1):185.
Article
PubMed
PubMed Central
Google Scholar
Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, Auvert B. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009;199(7):958–64.
Article
PubMed
PubMed Central
Google Scholar
Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret A, Baeten J, Bukusi EA, Cohen CR, Katabira E, Ronald A. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS ONE. 2009;4(4):e5272.
Article
PubMed
PubMed Central
Google Scholar
Kaul R, Nagelkerke NJ, Kimani J, Ngugi E, Bwayo JJ, MacDonald KS, Rebbaprgada A, Fonck K, Temmerman M, Ronald AR. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007;196(11):1692–7.
Article
PubMed
Google Scholar
Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362(5):427–39.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, Wu J, van Niekerk N, van de Wijgert J. HIV incidence remains high in KwaZulu-Natal, South Africa: evidence from three districts. PLoS ONE. 2012;7(4):e35278.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harrison A, Cleland J, Frohlich J. Young people’s sexual partnerships in KwaZulu-Natal, South Africa: patterns, contextual influences, and HIV risk. Stud Fam Plann. 2008;39(4):295–308.
Article
PubMed
PubMed Central
Google Scholar
Garnett GP, Anderson RM. Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci. 1993;342(1300):137–59.
Article
CAS
PubMed
Google Scholar
McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nunn A, McCormack S, Crook AM, Pool R, Rutterford C, Hayes R. Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10(1):99.
Article
PubMed
PubMed Central
Google Scholar
Jentsch U, Lunga P, Lacey C, Weber J, Cairns J, Pinheiro G, Joseph S, Stevens W, McCormack S. The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301). PLoS ONE. 2012;7(9):e42322.
Article
CAS
PubMed
PubMed Central
Google Scholar
Delany-Moretlwe S, Jentsch U, Weiss H, Moyes J, Ashley-Morrow R, Stevens W, Mayaud P. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population. Sex Transm Infect. 2010;86(1):46–50.
Article
PubMed
Google Scholar
de Bruyn G, Shiboski S, van der Straten A, Blanchard K, Chipato T, Ramjee G, Montgomery E, Padian N. The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect. 2011;87(4):301–5.
Article
PubMed
Google Scholar
Auvert B, Ballard R, Campbell C, Caraël M, Carton M, Fehler G, Gouws E, MacPhail C, Taljaard D, Van Dam J. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS. 2001;15(7):885–98.
Article
CAS
PubMed
Google Scholar
Rajagopal S, Magaret A, Mugo N, Wald A. Incidence of herpes simplex virus type 2 infections in Africa: a systematic review. Open Forum Infect Dis. 2014;1:ofu043.
Article
PubMed
PubMed Central
Google Scholar
Okuku HS, Sanders EJ, Nyiro J, Ngetsa C, Ohuma E, McClelland RS, Price MA, Graham SM. Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior. Sex Transm Dis. 2011;38(9):837–44.
Article
PubMed
PubMed Central
Google Scholar
Gallo MF, Warner L, Macaluso M, Stone KM, Brill I, Fleenor ME, Hook EW III, Austin HD, Lee FK, Nahmias AJ. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis. 2008;35(7):679–85.
Article
PubMed
Google Scholar
Watson-Jones D, Weiss HA, Rusizoka M, Baisley K, Mugeye K, Changalucha J, Everett D, Balira R, Knight L, Ross D. Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr. 2007;46(5):631.
Article
PubMed
PubMed Central
Google Scholar
Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11:130A–7A.
PubMed
Google Scholar
Hargreaves JR, Bonell CP, Boler T, Boccia D, Birdthistle I, Fletcher A, Pronyk PM, Glynn JR. Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS. 2008;22(3):403–14.
Article
PubMed
Google Scholar
Van de Laar M, Termorshuizen F, Slomka M, Van Doornum G, Ossewaarde J, Brown D, Coutinho R, Van den Hoek J. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors. Int J Epidemiol. 1998;27(1):127–34.
Article
PubMed
Google Scholar
Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12(1):e1001778.
Article
PubMed
PubMed Central
Google Scholar
Polis CB, Phillips SJ, Curtis KM, Westreich DJ, Steyn PS, Raymond E, Hannaford P, Turner AN. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception. 2014;90(4):360–90.
Article
CAS
PubMed
Google Scholar
McCoy SI, Zheng W, Montgomery ET, Blanchard K, van Der Straten A, de Bruyn G, Padian NS. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS. 2013;27(6):1001–9.
Article
CAS
PubMed
Google Scholar
Noguchi L, Hillier S, Richardson B, Chirenje Z, Balkus J, Piper J, Marrazzo J. O18. 2 Injectable progestin contraception and acquisition of hsv-2 infection among South African women participating in the voice trial. Sex Transm Infect. 2015;91(Suppl 2):A65.
Article
Google Scholar
Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, Kamb M, Wald A. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med. 2009;169(13):1233.
Article
PubMed
PubMed Central
Google Scholar